| 发明名称 |
Enzalutamide in combination with Afuresertib for the treatment of cancer |
| 摘要 |
A novel combination comprising an androgen receptor inhibitor, for example: 4- (3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2- fluoro-N-methylbenzamide or a pharmaceutically acceptable salt thereof, and an AKT inhibiting compound, for example: |
| 申请公布号 |
AU2014330780(A1) |
申请公布日期 |
2016.03.24 |
| 申请号 |
AU20140330780 |
申请日期 |
2014.10.01 |
| 申请人 |
NOVARTIS AG |
发明人 |
CORNFELD, MARK J.;KUMAR, RAKESH;MORRIS, SHANNON RENAE |
| 分类号 |
A61K31/4155;A61K31/4166;A61K31/58;A61K45/06;A61P35/00;A61P35/02 |
主分类号 |
A61K31/4155 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
